Autonomix Medical, Inc. Common Stock (AMIX) Financial Statements
Historical financial data — 18 statements covering
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate...
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period |
|---|
Balance Sheet Summary (Q1 FY2027)
Autonomix Medical, Inc. Common Stock (AMIX) Financial Statements & Revenue History
Autonomix Medical, Inc. Common Stock (AMIX) is a US-listed stock operating in the Healthcare sector, specifically the Surgical & Medical Instruments & Apparatus industry trading at $2.87 with a market capitalization of $0. This page provides 18 historical financial statements for Autonomix Medical, Inc. Common Stock, including income statement, balance sheet, and cash flow data across multiple reporting periods....
AMIX Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Autonomix Medical, Inc. Common Stock's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether AMIX is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track AMIX's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Autonomix Medical, Inc. Common Stock converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of AMIX's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use AMIX Financial Data
Investors use Autonomix Medical, Inc. Common Stock's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare AMIX's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how AMIX's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View AMIX's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Autonomix Medical, Inc. Common Stock's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.AMIX trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.